South Korea Meningococcal Vaccine Market Size, Share, and COVID-19 Impact Analysis, By Vaccine Type (Polysaccharide Vaccines, Conjugate Vaccines, MenB Vaccines, Combination Vaccines), By Age Group (Infants, Children, Adolescents, Adults), and South Korea Meningococcal Vaccine Market Insights, Industry Trend, Forecasts to 2035

South Korea Meningococcal Vaccine Market Insights Forecasts to 2035

• The South Korea Meningococcal Vaccine Market Size was Estimated at USD 18.65 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.91% from 2025 to 2035
• The South Korea Meningococcal Vaccine Market Size is Expected to Reach USD 47.7 Million by 2035

According to a research report published by Spherical Insights & Consulting, The South Korea Meningococcal Vaccine Market Size is anticipated to reach USD 47.7 Million by 2035, growing at a CAGR of 8.91% from 2025 to 2035. The market is driven by increasing incidence of meningococcal infections, government immunization programs, rising awareness about vaccination, and adoption of conjugate vaccines for better immunogenicity.

Market Overview

The South Korea meningococcal vaccine market consists of vaccines that prevent infections caused by Neisseria meningitidis, including invasive meningococcal disease. There are a variety of reasons that the South Korean meningococcal vaccine market is growing, an increase in awareness of vaccinations, upticks in incidences of meningococcal disease amongst the adolescent/young adult population, and immunization campaigns led by the South Korean government. The conjugate vaccines used throughout the country provide an increased duration of immunity and decreased carriage factors, and polysaccharide/multi-vaccine versions exist for specific niche populations. Meningococcal vaccines are dispensed at hospitals, retail pharmacies, and by online access through internet pharmacies. Even though there are high costs, as well as cold-chain storage needing to occur at the healthcare facility level before patients can gain interest, providers and retailers throughout have the South Korean meningococcal vaccine market positioned for sustained growth due to robust public health engagement and increased demand for preventive healthcare.

Report Coverage

This research report categorizes the market for the South Korea meningococcal vaccine market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea meningococcal vaccine market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea meningococcal vaccine market.

The market is driven by the increasing government immunization programmes, the rising rates of meningococcal infection, growing public awareness of vaccination, and the increasing uptake of conjugate vaccines for their increased immunogenicity and duration of protective effect. There is also increased uptake in the market, as vaccination coverage of adolescents and high-risk adults expands.

Restraining Factors

Market growth is restrained by cost of vaccines, cold-chain storage, limited infrastructure and access in some areas, and competition from other vaccines and preventive strategies.

Market Segmentation

The South Korea meningococcal vaccine market share is classified into vaccine type and age group.

• The conjugate vaccines segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea meningococcal vaccine market is segmented by vaccine type into polysaccharide vaccines, conjugate vaccines, MenB vaccines, and combination vaccines. Among these, the conjugate vaccines segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. Conjugate vaccines are in widespread use as a result of their superior immunogenicity and duration of protection, as well as their use in infancy and in young children.

• The infants segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea meningococcal vaccine market is segmented by age group into infants, children, adolescents, and adults. Among these, the infants segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to national immunization programs, age of vaccination, and high awareness of the need to prevent neonates and young children from contracting meningococcal infections.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea meningococcal vaccine market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Pfizer Inc.
• GlaxoSmithKline plc
• Sanofi Pasteur
• Merck & Co., Inc.
• Novartis AG
• Baxter International Inc.
• Serum Institute of India Pvt. Ltd.
• Biomed Pvt. Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea meningococcal vaccine market based on the below-mentioned segments:

South Korea Meningococcal Vaccine Market, By Vaccine Type

• Polysaccharide Vaccines
• Conjugate Vaccines
• MenB Vaccines
• Combination Vaccines

South Korea Meningococcal Vaccine Market, By Age Group

• Infants
• Children
• Adolescents
• Adults